Capecitabine and oxaliplatin in the adjuvant treatment of stage III (Dukes' C) colon cancer

Technology appraisal guidance
Reference number: TA100
Published: 26 April 2006

Appendix B: proposal paper presented to the Institute's Guidance Executive

Appendix B: proposal paper presented to the Institute's Guidance Executive

Appendix B: proposal paper presented to the Institute's Guidance Executive
19 April 2011
(445.21 Kb 9 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 15 April 2011